🇺🇸 FDA
Patent

US 8652475

Inhibition of factor B, the alternative complement pathway and methods related thereto

granted A61KA61K2039/505A61K2039/544

Quick answer

US patent 8652475 (Inhibition of factor B, the alternative complement pathway and methods related thereto) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/505, A61K2039/544, A61K39/3955, A61K45/06